Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000494204 | SCV000582364 | pathogenic | not provided | 2023-04-21 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25712757, 30055086, 33091211, 34217350) |
Ambry Genetics | RCV001267141 | SCV001445322 | likely pathogenic | Inborn genetic diseases | 2018-04-09 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000494204 | SCV001447369 | likely pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV000210625 | SCV002760104 | likely pathogenic | Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies | 2022-11-29 | criteria provided, single submitter | research | |
OMIM | RCV000210625 | SCV000266813 | pathogenic | Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies | 2022-12-19 | no assertion criteria provided | literature only | |
Genome |
RCV000509419 | SCV000606929 | not provided | MEIS2-related disorder | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |